Genelux (GNLX) Non Operating Income (2022 - 2026)

Genelux (GNLX) recorded quarterly Non Operating Income of $243000.0 in Q1 2026, up 47.27% quarter-over-quarter from $165000.0 in Q4 2025, and down 25.0% on a YoY basis from $324000.0 in Q1 2025.

Genelux (GNLX) Non Operating Income (2022 - 2026) Analysis & Trends

Genelux's Non Operating Income history runs 5 years deep, the most recent figure standing at $243000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income fell 25.0% year-over-year to $243000.0; the TTM figure through Mar 2026 stood at $988000.0 (down 47.61% YoY), while the FY2025 annual figure was $1.1 million, down 41.49% from the prior year.
  • Non Operating Income was $243000.0 for Q1 2026 at Genelux, up from $165000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $772000.0 in Q4 2024 to a low of -$3.9 million in Q1 2023.
  • Historically, Non Operating Income has averaged -$115266.7 across 5 years, with a median of $243000.0 in 2026.
  • The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 1347.37% in 2024, then plunged 78.63% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$401000.0 in 2022, then soared by 158.35% to $234000.0 in 2023, then surged by 229.91% to $772000.0 in 2024, then slumped by 78.63% to $165000.0 in 2025, then jumped by 47.27% to $243000.0 in 2026.
  • The last three Non Operating Income figures came in at $243000.0 (Q1 2026), $165000.0 (Q4 2025), and $244000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Genelux 129.36 Mn 129.36 Mn - 243,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 243,000.00
Dec 31, 2025 165,000.00
Sep 30, 2025 244,000.00
Jun 30, 2025 336,000.00
Mar 31, 2025 324,000.00
Dec 31, 2024 772,000.00
Sep 30, 2024 474,000.00
Jun 30, 2024 316,000.00
Mar 31, 2024 265,000.00
Dec 31, 2023 234,000.00
Sep 30, 2023 -38,000.00
Jun 30, 2023 -426,000.00
Mar 31, 2023 -3.90 Mn
Dec 31, 2022 -401,000.00
Sep 30, 2022 -335,000.00